Post-op patients on EPA maintain body weight

16 April 2009

New research from Trinity College Dublin, Ireland, showed omega-3 fatty acids given as part of an oral nutritional supplement resulted in the  preservation of muscle mass in patients undergoing surgery for  esopahageal cancer, a procedure normally associated with significant  weight loss and quality-of-life issues.

Published in the April issue of the Annals of Surgery, the team of  researchers found that patients given the standard feed (without  omega-3) suffered clinically-severe weight loss post surgery - losing an  average of 4 lbs of muscle mass after such procedure, whereas in the  group also taking 2.2g of eicosapentanoic acid per day maintained all  aspects of their body composition

Previous studies had found that nutritional supplements containing one  form of omega 3 fat, EPA, significantly reduced weight loss among  inoperable cancer patients. The Irish researchers hypothesized that a  nutritional supplement rich in calories and a high dose of EPA would  stem the debilitating weight loss seen in patients following esophageal  surgery, which is one of the most stressful and serious operations a  patient can undergo.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight